Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609947 · ClinicalTrials.gov registry record · NA
Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries.
A NA study, sponsored by Medtronic Vascular.
- Completed
- Registry status
- NA
- Development phase
- 241
- Enrollment target
NCT00609947 is a NA study that has completed, run by Medtronic Vascular. The registered enrollment target is 241 participants.
The verdict
NCT00609947, a NA study, has completed, sponsored by Medtronic Vascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 241 participants
- Enrollment target
Study Summary
The objective of this study is to verify the safety and efficacy of the Endeavor Zotarolimus-Eluting Coronary Stent System for improving coronary luminal diameter in patients with ischemic heart disease due to de novo lesions of length ≤27 mm in native coronary arteries with reference vessels ≥ 2.25 mm to ≤ 2.75 mm.
Interventions
- DEVICE Endeavor Zotarolimus-Eluting Coronary Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2008-01 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00609947
The ClinicalTrials.gov registry entry for NCT00609947 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 241 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Vascular, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endeavor Zotarolimus-Eluting Coronary Stent is the first listed.
NCT00609947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00609947 about?
NCT00609947 is a clinical study titled "Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries.". The objective of this study is to verify the safety and efficacy of the Endeavor Zotarolimus-Eluting Coronary Stent System for improving coronary luminal diameter in patients with ischemic heart disease due to de novo lesions of length ≤27 mm in native coronary arteries with reference vessels ≥ 2.25...
What is the current status of trial NCT00609947?
This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2008-01. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00609947?
The interventions under investigation include: Endeavor Zotarolimus-Eluting Coronary Stent (DEVICE).
Who is sponsoring clinical trial NCT00609947?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.